Form 8-K - Current report:
SEC Accession No. 0001140361-21-014426
Filing Date
2021-04-27
Accepted
2021-04-27 09:20:17
Documents
63
Period of Report
2021-04-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10023647_8k.htm 8-K 25888
2 EXHIBIT 99.1 brhc10023647_ex99-1.htm EX-99.1 18898
3 EXHIBIT 99.2 brhc10023647_ex99-2.htm EX-99.2 182273
4 brhc10023647_ex99-2slide1.jpg GRAPHIC 80878
5 brhc10023647_ex99-2slide2.jpg GRAPHIC 220445
6 brhc10023647_ex99-2slide3.jpg GRAPHIC 124527
7 brhc10023647_ex99-2slide4.jpg GRAPHIC 198807
8 brhc10023647_ex99-2slide5.jpg GRAPHIC 53529
9 brhc10023647_ex99-2slide6.jpg GRAPHIC 193961
10 brhc10023647_ex99-2slide7.jpg GRAPHIC 184011
11 brhc10023647_ex99-2slide8.jpg GRAPHIC 96854
12 brhc10023647_ex99-2slide9.jpg GRAPHIC 53356
13 brhc10023647_ex99-2slide10.jpg GRAPHIC 142735
14 brhc10023647_ex99-2slide11.jpg GRAPHIC 104610
15 brhc10023647_ex99-2slide12.jpg GRAPHIC 121497
16 brhc10023647_ex99-2slide13.jpg GRAPHIC 54016
17 brhc10023647_ex99-2slide14.jpg GRAPHIC 121925
18 brhc10023647_ex99-2slide15.jpg GRAPHIC 143011
19 brhc10023647_ex99-2slide16.jpg GRAPHIC 134091
20 brhc10023647_ex99-2slide17.jpg GRAPHIC 52546
21 brhc10023647_ex99-2slide18.jpg GRAPHIC 105692
22 brhc10023647_ex99-2slide19.jpg GRAPHIC 148985
23 brhc10023647_ex99-2slide20.jpg GRAPHIC 166616
24 brhc10023647_ex99-2slide21.jpg GRAPHIC 133415
25 brhc10023647_ex99-2slide22.jpg GRAPHIC 192619
26 brhc10023647_ex99-2slide23.jpg GRAPHIC 121500
27 brhc10023647_ex99-2slide24.jpg GRAPHIC 145271
28 brhc10023647_ex99-2slide25.jpg GRAPHIC 48159
29 brhc10023647_ex99-2slide26.jpg GRAPHIC 114283
30 brhc10023647_ex99-2slide27.jpg GRAPHIC 41182
31 brhc10023647_ex99-2slide28.jpg GRAPHIC 135861
32 brhc10023647_ex99-2slide29.jpg GRAPHIC 124601
33 brhc10023647_ex99-2slide30.jpg GRAPHIC 50294
34 brhc10023647_ex99-2slide31.jpg GRAPHIC 35132
35 brhc10023647_ex99-2slide32.jpg GRAPHIC 191119
36 brhc10023647_ex99-2slide33.jpg GRAPHIC 124367
37 brhc10023647_ex99-2slide34.jpg GRAPHIC 112248
38 brhc10023647_ex99-2slide35.jpg GRAPHIC 133315
39 brhc10023647_ex99-2slide36.jpg GRAPHIC 147455
40 brhc10023647_ex99-2slide37.jpg GRAPHIC 126735
41 brhc10023647_ex99-2slide38.jpg GRAPHIC 139913
42 brhc10023647_ex99-2slide39.jpg GRAPHIC 111988
43 brhc10023647_ex99-2slide40.jpg GRAPHIC 124150
44 brhc10023647_ex99-2slide41.jpg GRAPHIC 120542
45 brhc10023647_ex99-2slide42.jpg GRAPHIC 37639
46 brhc10023647_ex99-2slide43.jpg GRAPHIC 151205
47 brhc10023647_ex99-2slide44.jpg GRAPHIC 48871
48 brhc10023647_ex99-2slide45.jpg GRAPHIC 142732
49 brhc10023647_ex99-2slide46.jpg GRAPHIC 181821
50 brhc10023647_ex99-2slide47.jpg GRAPHIC 114362
51 brhc10023647_ex99-2slide48.jpg GRAPHIC 136537
52 brhc10023647_ex99-2slide49.jpg GRAPHIC 128552
53 brhc10023647_ex99-2slide50.jpg GRAPHIC 97015
54 brhc10023647_ex99-2slide51.jpg GRAPHIC 157731
55 brhc10023647_ex99-2slide52.jpg GRAPHIC 108504
56 brhc10023647_ex99-2slide53.jpg GRAPHIC 107956
57 brhc10023647_ex99-2slide54.jpg GRAPHIC 135722
58 brhc10023647_ex99-2slide55.jpg GRAPHIC 126143
59 brhc10023647_ex99-2slide56.jpg GRAPHIC 125254
60 brhc10023647_ex99-2slide57.jpg GRAPHIC 43432
61 brhc10023647_ex99-2slide58.jpg GRAPHIC 160394
62 brhc10023647_ex99-2slide59.jpg GRAPHIC 171776
63 image00001.jpg GRAPHIC 2533
  Complete submission text file 0001140361-21-014426.txt   10088531
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 21856202
SIC: 2834 Pharmaceutical Preparations